HC Wainwright & Co. Maintains Buy on GlycoMimetics, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has maintained a Buy rating on GlycoMimetics (NASDAQ:GLYC) with an $8 price target. This reaffirms the firm's positive outlook on the company.
March 27, 2024 | 5:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. maintains a Buy rating on GlycoMimetics with an $8 price target, indicating a positive outlook.
The maintenance of a Buy rating and an $8 price target by a reputable analyst firm like HC Wainwright & Co. suggests a strong belief in the potential of GlycoMimetics. This could positively influence investor sentiment and potentially lead to an increase in the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100